Dexrazoxane Prophylaxis
Dexrazoxane Prophylaxis is a cardioprotective pharmacological intervention that selectively mitigates anthracycline-induced cardiotoxicity through topoisomerase IIβ inhibition and iron chelation without compromising antitumor efficacy.
4
Publications
634
Citations
25
Authors
11
Institutions
Publications per year
2017–2026
1
Parents
4
Cameron K. Tebbi, Wendy B. London, Debra L. Friedman et al. · Journal of Clinical Oncology · 2007 · 485 citations · Full text
Medicine, Oncology, Pharmacology +17
Treatment of anthracycline extravasation with dexrazoxane.
Seppo W. Langer, Maxwell Sehested, Jensen Pb · PubMed · 2000 · 112 citations
Nathan J. Schloemer, Molly Brickler, Raymond G. Hoffmann et al. · Journal of Pediatric Hematology/Oncology · 2017 · 19 citations
Medicine, Oncology, Pharmacotherapy +17
1–4 of 4
25
1
h-index
University of Rochester Medical Center, United States
1 publications · 485 citations
1
h-index
1
h-index
1
h-index
Roswell Park Comprehensive Cancer Center, United States
1 publications · 485 citations
1
h-index
1–5 of 25
11
Children's Hospital of Wisconsin
Milwaukee, United States
1 h-index
1 publications
19 citations

St. Jude Children's Research Hospital
Memphis, United States
1 h-index
10 publications
4.8K citations
University of Washington
Seattle, United States
1 h-index
3 publications
1.5K citations

Medical College of Wisconsin
Milwaukee, United States
1 h-index
1 publications
19 citations
University of Rochester Medical Center
Rochester, United States
1 h-index
10 publications
4.8K citations
University of Florida
Gainesville, United States
1 h-index
7 publications
3.4K citations
Fred Hutch Cancer Center
Seattle, United States
1 h-index
10 publications
4.8K citations
Quantitative BioSciences
Solana Beach, United States
1 h-index
3 publications
57 citations
1–8 of 11
1 publications · 485 citations
1
h-index
1 publications · 19 citations
1
h-index
1 publications · 18 citations
1
h-index
Repository · 1 publications · 112 citations
1
h-index
1–4